Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2022
>
Researchers Harness Probiotics to Deliver Parkinson’s Disease Treatment
Researchers Harness Probiotics to Deliver Parkinson’s Disease Treatment
Read also
Eli Lilly
Eli Lilly picks Virginia for $5bn drug manufacturing plant
Modus
Modus data on sevuparin for CKD to be presented at global GAG symposium
Biocon Biologics
Biocon Biologics Says FDA Approves Bosaya And Aukelso As Denosumab Biosimilars
Nurix reports
Nurix reports promising preclinical data for IRAK4 degrader GS-6791
